Zobrazeno 1 - 10 of 19 pro vyhledávání: '"Stephanie A Blankenstein"'
1
Akademický článek
Interferon-gamma signature as prognostic and predictive marker in macroscopic stage III melanoma
Autor: Annegien Broeks, Michel W J M Wouters, Georgina V Long, Richard A Scolyer, Christian U Blank, Judith M Versluis, Karijn P M Suijkerbuijk, Petros Dimitriadis, Joyce Sanders, James S Wilmott, Alexander Maxwell Menzies, Yvonne M Schrage, Stephanie A Blankenstein, Robert Elens, Willeke A M Blokx, Winan van Houdt, Alexander C J van Akkooi
Publikováno v: Journal for ImmunoTherapy of Cancer, Vol 12, Iss 4 (2024)
Background A substantial proportion of patients with macroscopic stage III melanoma do not benefit sufficiently from adjuvant anti-PD-1 therapy, as they either recur despite therapy or would never have recurred. To better inform adjuvant treatment se
Externí odkaz: https://doaj.org/article/e0b90991b4304091afe1ffd233fc064c
Zobrazit plný text záznamu
2
18F-FDG PET/CT During Neoadjuvant Targeted Therapy in Prior Unresectable Stage III Melanoma Patients
Autor: Bernies, van der Hiel, Stephanie A, Blankenstein, Else A, Aalbersberg, Maurits, Wondergem, Marcel P M, Stokkel, Bart A, van de Wiel, W Martin C, Klop, Alexander C J, van Akkooi, John B, Haanen
Publikováno v: Clinical Nuclear Medicine. 47:583-589
The aim of this study was to investigate whether 18F-FDG PET/CT can predict histopathological response or recurrence in BRAF-mutated unresectable locally advanced stage III melanoma treated with neoadjuvant BRAF/MEK inhibition followed by resection a
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0f426e969687282483d368cca4afa0fc
https://doi.org/10.1097/rlu.0000000000004217
Zobrazit plný text záznamu
3
Postoperative Radiotherapy in Stage I-III Merkel Cell Carcinoma
Autor: Lukas B. Been, Olga Hamming-Vrieze, Sonja Levy, Lisa Tans, Mathilde Jalving, Alexander C.J. van Akkooi, Dirk J. Grünhagen, Stephanie A. Blankenstein, Margot E T Tesselaar
Publikováno v: Radiotherapy and Oncology, 166, 203-211. ELSEVIER IRELAND LTD
Radiotherapy and Oncology, 166, 203-211. Elsevier Ireland Ltd
BACKGROUND: Postoperative radiotherapy (PORT) is currently recommended for the treatment of Merkel cell carcinoma. Nevertheless, deviations occur frequently due to the generally elderly and frail patient population. We aimed to evaluate the influence
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::377a37ac57f705b3b0ba50350adae0dc
https://hdl.handle.net/11370/099f9e92-2459-4695-9589-5d28ffb6fc4a
Zobrazit plný text záznamu
4
ASO Visual Abstract: Is a History of Optimal Staging by SLNB in the Era Prior to Adjuvant Therapy Associated with Improved Outcome Once Melanoma Patients have Progressed to Advanced Disease?
Autor: Stephanie A. Blankenstein, Johannes J. Bonenkamp, Maureen J. B. Aarts, Franchette W. P. J. van den Berkmortel, Christian U. Blank, Willeke A. M. Blokx, Marye J. Boers-Sonderen, Alfons J. M. van den Eertwegh, Margreet G. Franken, Jan Willem B. de Groot, John B. A. G. Haanen, Geke A. P. Hospers, Ellen W. Kapiteijn, Olivier J. van Not, Djura Piersma, Rozemarijn S. van Rijn, Karijn P. M. Suijkerbuijk, Astrid A. M. van der Veldt, Gerard Vreugdenhil, Hans M. Westgeest, Michel W. J. M. Wouters, Alexander C. J. van Akkooi
Publikováno v: Annals of Surgical Oncology, 30, 587-588
Annals of surgical oncology, 30(1), 587-588. SPRINGER
Annals of Surgical Oncology, 30, 1, pp. 587-588
Annals of Surgical Oncology, 30, 587-588. SPRINGER
Annals of Surgical Oncology, 30(1), 587-588. Springer New York
Blankenstein, S A, Bonenkamp, J J, Aarts, M J B, van den Berkmortel, F W P J, Blank, C U, Blokx, W A M, Boers-Sonderen, M J, van den Eertwegh, A J M, Franken, M G, de Groot, J W B, Haanen, J B A G, Hospers, G A P, Kapiteijn, E W, van Not, O J, Piersma, D, van Rijn, R S, Suijkerbuijk, K P M, van der Veldt, A A M, Vreugdenhil, G, Westgeest, H M, Wouters, M W J M & van Akkooi, A C J 2023, ' ASO Visual Abstract : Is a History of Optimal Staging by SLNB in the Era Prior to Adjuvant Therapy Associated with Improved Outcome Once Melanoma Patients have Progressed to Advanced Disease? ', Annals of Surgical Oncology, vol. 30, no. 1, pp. 587-588 . https://doi.org/10.1245/s10434-022-12719-2
Item does not contain fulltext 01 januari 2023
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1480b0963fbc242733d1a1605fef0bb9
http://hdl.handle.net/2066/290963
Zobrazit plný text záznamu
6
Reversal of pre-existing NGFR-driven tumor and immune therapy resistance
Autor: Christian U. Blank, Elisa A. Rozeman, David W. Vredevoogd, Hugo M. Horlings, Stephanie A. Blankenstein, Marieke Brüggemann, Julia Boshuizen, Beaunelle de Bruijn, Juliana C.N. Kenski, Max F. Madu, Keith T. Flaherty, Alexander C.J. van Akkooi, Ji-Ying Song, Dennie T. Frederick, Mara Parren, Oscar Krijgsman, Daniel S. Peeper, Maarten A. Ligtenberg, Genevieve M. Boland
Publikováno v: Nature communications, 11(1):3946. Nature Publishing Group
Nature Communications
Nature Communications, Vol 11, Iss 1, Pp 1-13 (2020)
Melanomas can switch to a dedifferentiated cell state upon exposure to cytotoxic T cells. However, it is unclear whether such tumor cells pre-exist in patients and whether they can be resensitized to immunotherapy. Here, we chronically expose (patien
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::169ac84a0fc19e200b0badf8c6a353cf
https://pure.amc.nl/en/publications/reversal-of-preexisting-ngfrdriven-tumor-and-immune-therapy-resistance(dda4d8a2-a72f-4a5a-b05a-12bc7aa97702).html
Zobrazit plný text záznamu
7
Surgery for Unresectable Stage IIIC and IV Melanoma in the Era of New Systemic Therapy
Autor: Alexander C.J. van Akkooi, Michel W.J.M. Wouters, Rozemarijn S. van Rijn, John B. A. G. Haanen, Franchette W P J van den Berkmortel, Karijn P M Suijkerbuijk, Djura Piersma, Margreet G. Franken, Ellen Kapiteijn, Maureen J.B. Aarts, Alfons J.M. van den Eertwegh, Albert J. ten Tije, Astrid A M van der Veldt, Jan Willem B. de Groot, Marye Boers-Sonderen, Stephanie A. Blankenstein, Geke A. P. Hospers, Gerard Vreugdenhil
Publikováno v: Cancers
Volume 12
Issue 5
Cancers, 12(5). Multidisciplinary Digital Publishing Institute (MDPI)
Cancers, 12, 5
Cancers, 12
Cancers, 12(5):1176. MDPI AG
Blankenstein, S A, Aarts, M J B, Van Den Berkmortel, F W P J, Boers-Sonderen, M J, Van Den Eertwegh, A J M, Franken, M G, De Groot, J W B, Haanen, J B A G, Hospers, G A P, Kapiteijn, E, Piersma, D, Van Rijn, R S, Suijkerbuijk, K P M, Ten Tije, A J, Van Der Veldt, A A M, Vreugdenhil, G, Wouters, M W J M & Van Akkooi, A C J 2020, ' Surgery for unresectable stage IIIC and IV melanoma in the era of new systemic therapy ', Cancers, vol. 12, no. 5, 1176 . https://doi.org/10.3390/cancers12051176
Cancers, 12(5):1176. Multidisciplinary Digital Publishing Institute (MDPI)
Cancers, Vol 12, Iss 1176, p 1176 (2020)
Cancers, 12(5). MDPI
Opportunities for surgical treatment in metastatic melanoma patients have re-emerged due to the development of novel systemic therapeutics over the past decade. The aim of this study is to present data on outcomes of surgery in patients with unresect
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::374209969b0e7dd99e2e49ed63adaa85
Zobrazit plný text záznamu
10
Surgery for Metastatic Melanoma: an Evolving Concept
Autor: Alexander C.J. van Akkooi, Alessandro Testori, Stephanie A. Blankenstein
Publikováno v: Current oncology reports. 21(11)
This review describes the evolving role of surgery in stage III and IV melanoma. Surgery has been the first option to cure melanoma patients at initial diagnosis of metastatic spread: a complete surgical excision of the disease either in stage III or
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dce26c2494efa08f83fc467399568ade
https://pubmed.ncbi.nlm.nih.gov/31696407
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje